Search company, investor...

Predict your next investment

Cambridge Innovation Capital company logo
Venture Capital
FINANCE | Investment Firms & Funds
cic.vc

Investments

80

Portfolio Exits

6

Funds

4

About Cambridge Innovation Capital

Cambridge Innovation Capital combines a unique relationship with the University of Cambridge with deep financial and industry links to build rapidly growing intellectual property rich companies in the Cambridge Cluster. The company is committed to support leading businesses from brilliant technologies - with the support of influential figures in the sector and a patient capital structure.

Headquarters Location

Hauser Forum 3 Charles Babbage Road

Cambridge, England, CB3 0GT,

United Kingdom

+44 (0)1223 764875

Want to inform investors similar to Cambridge Innovation Capital about your company?

Submit your Analyst Briefing to get in front of investors, customers, and partners on CB Insights’ platform.

Research containing Cambridge Innovation Capital

Get data-driven expert analysis from the CB Insights Intelligence Unit.

CB Insights Intelligence Analysts have mentioned Cambridge Innovation Capital in 1 CB Insights research brief, most recently on Jun 30, 2021.

Latest Cambridge Innovation Capital News

Innovate Cambridge gets Arm and Microsoft support to boost tech ecosystem

Dec 8, 2022

Innovate Cambridge gets Arm and Microsoft support to boost tech ecosystem An initiative looking to promote innovation in the Cambridge tech ecosystem has received over 100 charter signatures from the likes of Arm, Microsoft and AstraZeneca. Innovate Cambridge was launched in September by Cambridge Enterprise, Cambridge Innovation Capital and the University of Cambridge to promote the city on the global stage. It has appointed CogX co-founder and UK Government advisor Tabitha Goldstaub as executive director. Innovate Cambridge has also appointed Lord David Willetts, who served as minister for university and science and sits on the board of Cambridge-based Darktrace, as chair of its steering committee. Diarmuid O’Brien, CEO of Cambridge Enterprise and co-founder of Innovate Cambridge, told UKTN that the initiative is “trying to find a way to accelerate how quickly Cambridge could deliver impact globally” and find new opportunities to boost its tech standing. Over 100 organisations have already signed up to Innovate Cambridge’s charter, which commits members to promote the initiative, provide leadership and shape the group’s direction over the next decade. “Cambridge needs to compete with other ecosystems for talent, capital, quality of life and innovation resources and we must ensure our proposition remains both compelling and differentiated,” the charter states. In addition to Arm , Microsoft and AstraZeneca, the charter has attracted signatures from local government, two Cambridge universities, investors, infrastructure operators, accelerators and incubators. “This is a very inclusive group that brings together all of the actors needed to move the needle for the Cambridge ecosystem,” added O’Brien. Innovate Cambridge to build on tech foundations Cambridge, which has earned the nickname Silicon Fen, is home to many high-tech and life science businesses. Among them are chip designer Arm , fabless semiconductor spinout Cambridge GaN Devices and graphene startup Paragraf . “We don’t want a city or an area with those that have and those that don’t have, we want the entire Cambridge ecosystem to benefit from the impact that’s been born here,” said Michael Anstey, partner at Cambridge Innovation Capital and co-founder of Innovate Cambridge. Now the plan is for Innovate Cambridge to bring all the businesses together to “roadmap” the ambition and direction of the Cambridge area. “There’s been agreement around that it’s about impact, economic growth and improved social inclusion,” added O’Brien. Image credit: Innovate Cambridge Among the “obvious” areas that need to be addressed are attracting and keeping the necessary talent, bringing in more capital and developing opportunities in Cambridge and nearby. The charter outlines 10 areas in total that Innovate Cambridge wish to address and will be looked at in the next sixth months, with the Boston Consulting Group creating a vision for the area. Signing the initiative’s charter does not currently come with a specific set of requirements, but will signatories will consider the best intentions for the area and champion Cambridge to the government. “We’re going to get all of the key actors in a room on a regular basis over the next period to dream ambitiously for Cambridge,” said O’Brien. Once a concrete direction has been decided for Innovate Cambridge, which should be decided in the next 12 months, signatories will ramp up their own actions of support. “Whatever we do should be bulk connected to London and elevate both jurisdictions,” continued O’Brien. “But I think there’s a Cambridge story that can be told which is separate to London and needs to be framed.”

Cambridge Innovation Capital Investments

80 Investments

Cambridge Innovation Capital has made 80 investments. Their latest investment was in Seldon as part of their Series B on March 3, 2023.

CBI Logo

Cambridge Innovation Capital Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

3/16/2023

Series B

Seldon

$20M

No

7

12/14/2022

Series B

STORM Therapeutics

$30M

No

6

12/1/2022

Series C

Carrick Therapeutics

$25M

No

1

11/15/2022

Series B

Subscribe to see more

$99M

Subscribe to see more

10

9/12/2022

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

3/16/2023

12/14/2022

12/1/2022

11/15/2022

9/12/2022

Round

Series B

Series B

Series C

Series B

Series A

Company

Seldon

STORM Therapeutics

Carrick Therapeutics

Subscribe to see more

Subscribe to see more

Amount

$20M

$30M

$25M

$99M

$99M

New?

No

No

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

7

6

1

10

10

Cambridge Innovation Capital Portfolio Exits

6 Portfolio Exits

Cambridge Innovation Capital has 6 portfolio exits. Their latest portfolio exit was Sense Biodetection on February 01, 2023.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

2/1/2023

Acquired

$99M

6

11/6/2022

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

12/22/2021

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

5/5/2021

Corporate Majority

Subscribe to see more

$99M

Subscribe to see more

10

7/23/2019

Acquired

Subscribe to see more

$99M

Subscribe to see more

10

Date

2/1/2023

11/6/2022

12/22/2021

5/5/2021

7/23/2019

Exit

Acquired

Acquired

Acquired

Corporate Majority

Acquired

Companies

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Valuation

$99M

$99M

$99M

$99M

$99M

Acquirer

Subscribe to see more

Subscribe to see more

Subscribe to see more

Subscribe to see more

Sources

6

10

10

10

10

Cambridge Innovation Capital Fund History

4 Fund Histories

Cambridge Innovation Capital has 4 funds, including Cambridge Fund II.

Closing Date

Fund

Fund Type

Status

Amount

Sources

4/25/2022

Cambridge Fund II

$286.45M

1

3/31/2019

Cambridge Fund III

$99M

10

8/19/2016

Cambridge Follow On Fund

$99M

10

8/12/2014

Cambridge Cluster Fund

Subscribe to see more

Subscribe to see more

$99M

10

Closing Date

4/25/2022

3/31/2019

8/19/2016

8/12/2014

Fund

Cambridge Fund II

Cambridge Fund III

Cambridge Follow On Fund

Cambridge Cluster Fund

Fund Type

Subscribe to see more

Status

Subscribe to see more

Amount

$286.45M

$99M

$99M

$99M

Sources

1

10

10

10

Cambridge Innovation Capital Team

2 Team Members

Cambridge Innovation Capital has 2 team members, including current Managing Partner, Andrew Williamson.

Name

Work History

Title

Status

Andrew Williamson

True North Venture Partners, MalibuIQ, Physic Ventures, and Lawrence Livermore National Laboratory

Managing Partner

Current

Subscribe to see more

Subscribe to see more

Subscribe to see more

Name

Andrew Williamson

Subscribe to see more

Work History

True North Venture Partners, MalibuIQ, Physic Ventures, and Lawrence Livermore National Laboratory

Title

Managing Partner

Subscribe to see more

Status

Current

Subscribe to see more

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.